Saturday, July 5, 2025

Latest:

Surviving cancer and tracheoesophageal fistula: Sandy Tovey’s journey
Handy ‘MasSpec Pen’ collection could help detect opioids from the skin
A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

Baylor Licensing Group

From The Labs

From the labs to commercialization: Baylor College of Medicine graduate starts Speratum CR to bring his own discovery to cancer patients

April 10, 2018 Baylor Licensing Group, LGA-PEI polymer delivery system, miR-198, pancreatic cancer, Research, Speratum

Dr. Christian Marín-Muller’s grandmother died of cancer before he was born. It saddens him that he never had the chance to meet her, but thanks

From The Labs

From the Labs to Commercialization: the Estes lab and ImmuCell Success Story

February 6, 2018 Baylor Licensing Group, calf gastroenteritis, gastroenteritis, ImmuCell, Mary Estes lab, rotavirus, rotavirus vaccine, scours, virus-like particles

Research discoveries at Baylor College of Medicine can potentially reach the point where they evolve into practical applications that improve the quality of life. After

Momentum

From the bench to the market place

June 4, 2014 Audrey M. Marks, Baylor College of Medicine, Baylor Licensing Group, Center for Cell and Gene Therapy, Houston, Michael Dilling, Research

Each year Baylor College of Medicine faculty, students and staff develop new therapeutics, devices, research tools, and uncover new methods in the biomedical field that

From the Labs: a closer look at metastatic medulloblastoma